Revealing the Common Mechanisms of Scutellarin in Angina Pectoris and Ischemic Stroke Treatment via a Network Pharmacology Approach

被引:16
|
作者
Meng Zi-qi [1 ]
Wu Jia-rui [1 ]
Zhu Ying-li [1 ]
Zhou Wei [1 ]
Fu Chang-geng [2 ]
Liu Xin-kui [1 ]
Liu Shu-yu [1 ]
Ni Meng-wei [1 ]
Guo Si-yu [1 ]
机构
[1] Beijing Univ Chinese Med, Sch Chinese Mat Med, Dept Clin Chinese Pharm, Beijing 100029, Peoples R China
[2] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing 100091, Peoples R China
基金
中国国家自然科学基金;
关键词
scutellarin; angina pectoris; ischemic stroke; network pharmacology; UPDATE; CELLS; BRAIN; BREVISCAPINE; DYSFUNCTION; ACTIVATION; DISEASES; DATABASE; EXTRACT; AGENT;
D O I
10.1007/s11655-020-2716-4
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective To investigate the shared mechanisms of scutellarin in angina pectoris (AP) and ischemic stroke (IS) treatment. Methods A network pharmacology approach was used to detect the potential mechanisms of scutellarin in AP and IS treatment by target prediction, protein-protein interaction (PPI) data collection, network construction, network analysis, and enrichment analysis. Furthermore, molecular docking simulation was employed to analyze the interaction between scutellarin and core targets. Results Two networks were established, including a disease-target network and a PPI network of scutellarin targets against AP and IS. Network analysis showed that 14 targets, namely, AKT1, VEGFA, JUN, ALB, MTOR, ESR1, MAPK8, HSP90AA1, NOS3, SERPINE1, FGA, F2, FOXO3, and STAT1, might be the therapeutic targets of scutellarin in AP and IS. Among them, NOS3 and F2 were recognized as the core targets. Additionally, molecular docking simulation confifirmed that scutellarin exhibited a relatively high potential for binding to the active sites of NOS3 and F2. Furthermore, enrichment analysis indicated that scutellarin might exert a therapeutic role in both AP and IS by regulating several important pathways, such as coagulation cascades, mitogen-activated protein kinase (MAPK) signaling pathway, phosphatidylinositol 3 kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway, Toll-like receptor signaling pathway, hypoxia inducible factor-1 (HIF-1) signaling pathway, forkhead box O (FoxO) signaling pathway, tumor necrosis factor (TNF) signaling pathway, adipocytokine signaling pathway, insulin signaling pathway, insulin resistance, and estrogen signaling pathway. Conclusions The shared underlying mechanisms of scutellarin on AP and IS treatment might be strongly associated with its vasorelaxant, anticoagulant, anti-inflammatory, and antioxidative effects as well as its effect on improving lipid metabolism.
引用
收藏
页码:62 / 69
页数:8
相关论文
共 50 条
  • [1] Revealing the Common Mechanisms of Scutellarin in Angina Pectoris and Ischemic Stroke Treatment via a Network Pharmacology Approach
    Zi-qi Meng
    Jia-rui Wu
    Ying-li Zhu
    Wei Zhou
    Chang-geng Fu
    Xin-kui Liu
    Shu-yu Liu
    Meng-wei Ni
    Si-yu Guo
    Chinese Journal of Integrative Medicine, 2021, 27 : 62 - 69
  • [2] Revealing the Common Mechanisms of Scutellarin in Angina Pectoris and Ischemic Stroke Treatment via A Network Pharmacology Approach
    MENG Zi-qi
    WU Jia-rui
    ZHU Ying-li
    ZHOU Wei
    FU Chang-geng
    LIU Xin-kui
    LIU Shu-yu
    NI Meng-wei
    GUO Si-yu
    Chinese Journal of Integrative Medicine, 2021, 27 (01) : 62 - 69
  • [3] Revealing the Common Mechanisms of Scutellarin in Angina Pectoris and Ischemic Stroke Treatment via A Network Pharmacology Approach
    MENG Ziqi
    WU Jiarui
    ZHU Yingli
    ZHOU Wei
    FU Changgeng
    LIU Xinkui
    LIU Shuyu
    NI Mengwei
    GUO Siyu
    Chinese Journal of Integrative Medicine, 2021, (01) : 62 - 69
  • [4] Revealing the action mechanisms of scutellarin against glioblastoma based on network pharmacology and experimental validation
    Sun, Junzhao
    Wang, Hongwei
    Cheng, Gang
    Zhang, Leiming
    Qu, Zhifeng
    Han, Chengchen
    Zheng, Wei
    Wu, Lin
    Zhang, Jianning
    FOOD SCIENCE AND TECHNOLOGY, 2022, 42
  • [5] Revealing the Pharmacological Mechanism of Acorus tatarinowii in the Treatment of Ischemic Stroke Based on Network Pharmacology
    Liu, FengZhi
    Zhao, Qian
    Liu, Suxian
    Xu, Yingzhi
    Zhou, Dongrui
    Gao, Ying
    Zhu, Lingqun
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [6] A Network Pharmacology Approach to Investigate the Active Compounds and Mechanisms of Musk for Ischemic Stroke
    Zhang, Changlin
    Liao, Yingdi
    Liu, Lingling
    Sun, Yifan
    Lin, Shaoqin
    Lan, Jiaying
    Mao, Hui
    Chen, Haoxuan
    Zhao, Yuanqi
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [7] Kuanxiong Aerosol () in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology
    Zhang Yu-zhuo
    Zeng Rui-xiang
    Zhou Yuan-shen
    Zhang Min-zhou
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2021, 27 (06) : 470 - 480
  • [8] A network pharmacology approach to investigate the mechanism of Shuxuening injection in the treatment of ischemic stroke
    Cui, Qian
    Zhang, Yu-liang
    Ma, Yu-hui
    Yu, Hao-yu
    Zhao, Xin-zhe
    Zhang, Li-hui
    Ge, Shao-qin
    Zhang, Guo-wei
    Qin, Xiu-de
    JOURNAL OF ETHNOPHARMACOLOGY, 2020, 257
  • [9] Kuanxiong Aerosol(宽胸气雾剂) in Treatment of Angina Pectoris:A Literature Review and Network Pharmacology
    ZHANG Yuzhuo
    ZENG Ruixiang
    ZHOU Yuanshen
    ZHANG Minzhou
    Chinese Journal of Integrative Medicine, 2021, 27 (06) : 470 - 480
  • [10] Kuanxiong Aerosol (宽胸气雾剂) in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology
    Yu-zhuo Zhang
    Rui-xiang Zeng
    Yuan-shen Zhou
    Min-zhou Zhang
    Chinese Journal of Integrative Medicine, 2021, 27 : 470 - 480